Consistently, our study showed that those with delayed and/or lower insulin secretion (i.e. IGT and CFRD) had attenuated insulin sensitivity compared with NGT and this decline could not be explained by differences in inflammation and nutritional status. This evidence concerns the gene INS and cystic fibrosis-related diabetes.